News and Trends 5 Jul 2018
Series A Round Could Bring French Microbiome Treatment for Bowel Disease Into the Clinic
Netbiotix has raised €7.5M to bring its lead candidate for inflammatory bowel disease into clinical trials. The treatment uses a bacterium found in the gut to prevent and dampen inflammation. The company, based in Paris, develops treatments for inflammatory bowel disease (IBD) that consist of a single microbial strain that interacts with cells in the […]